cerebrospinal fluid in animals. This report deals with one such study in the primate, Erythrocebus patas, selected because of the well documented similarities in cerebrospinal anatomy between man and monkey (Wood et al., 1977) . A comparison was made of the disposition of meptazinol following intrathecal and i.m. administration and on the direction of drug movement in the spinal canal of the monkey. 
MATERIALS AND METHODS

Compounds
Animals
Six female Red Patas monkeys weighing 4.8-5.9 kg, obtained from Shamrock Farms Ltd, Brighton, Sussex, were used. The animals were maintained on Mazuri Primate Diet (SDS Ltd, Witham, Essex) supplemented daily with fresh fruits.
Anaesthesia
Animals were fasted overnight for a period of up to 18 h before anaesthesia, but were allowed free access to water. Anaesthesia was induced by an i.v. injection of Althesin ("SarTan", Glaxovet, Greenford, UK.) via an indwelling 18-gauge venous cannula (British Viggo, Swindon, UK.), which had previously been placed in the recurrent tarsal vein on the posterolateral aspect of either the left or right hind leg. The anaesthetic agent was injected to effect. Following induction of anaesthesia, the trachea was intubated and connected to an anaesthetic machine via a Waters to-and-fro system (used semi-closed) for administration of oxygen at the rate of 50 ml min~x. This technique was adopted to prevent the occurrence of electrocardiographic changes associated with anoxia, which had previously been noted during anaesthesia with SarTan (Dhiri, 1984) . The animals were also connected to an ECG recorder (Seimens, Middlesex, U.K.) to monitor heart rate and ECG. Anaesthesia was maintained for the duration of the study by the continuous i.v. infusion of Althesin (0.72 mg min~l of a 1.2 mg ml" 1 solution in 0.9 % w/v saline), the infusion being started 20 min after the induction of anaesthesia.
Drug administration and sample collection
Intrathecal studies. The thoracic 9-10, thoracolumbar 12-1 and lumbar 3-A intervertebral spaces were tapped using 18-gauge spinal needles (Becton-Dickinson (U.K.) Ltd, Oxford, U.K.). The subarachnoid punctures were performed with the animals lying in left lateral recumbency and the needles were assumed to be in the intrathecal space when clear fluid was seen in the hub of the needles. CSF samples (0.25-0.75 ml) were collected in clear plastic vials and stored on dry ice.
As a prelude to the main investigation, a study in a single animal was undertaken in an attempt to determine the direction of CSF flow within the spinal canal. [ l4 C]-Sucrose (1 uCi ml-1 ) 100 ul was injected to one monkey (463) at the T12/L1 intervertebral space and the spinal needle withdrawn. Tritiated meptazinol 100 ul (concentration of meptazinol solution 5 mg ml" 1 ; unlabelled/ labelled ratio 95:5) was injected to three monkeys (465, 466, 468) at the level of the T12-S1 intervertebral space and the spinal needle withdrawn. The other two spinal needles were left in place and CSF collected every 30 min for up to 240 min.
I.m. studies. Subarachnoid puncture was performed at T12-S1 in four monkeys (464, 465, 466, 467) . Tritiated meptazinol 16 mg kg" 1 (unlabelled/labelled ratio 98.3:1.7) was injected to the quadriceps muscle band of the hind leg opposite to the leg that had been cannulated for the administration of anaesthesia. CSF, and blood samples (from the cannulated leg), were collected every 30 min for up to 240 min.
The animal usage in the various procedures {vide supra) is summarized in table I. An interval of 2 weeks was allowed for the two animals which were used for both intrathecal and i.m. studies. This was considered to be sufficient for all the meptazinol to have disappeared from the animals following the first of the procedures (Franklin and Aldridge, 1976) .
Measurement of radioactivity. Radioactivity in the samples of CSF and blood was determined by liquid scintillation spectrometry, using a Beckman LS3800 counter, and corrected for quench efficiency. In one monkey (465) various sections of (Franklin and Aldridge, 1976) which is highly hydrophilic, with minimal ability to cross the blood-brain barrier. Thus the radioactivity measured in the CSF is assumed to reflect unchanged meptazinol. On the other hand, the radioactivity measured in the plasma reflects both unchanged drug and its glucuronide conjugate.
RESULTS
Disposition of [ u C]-sucrose following intrathecal administration
The results of this study are presented in table II and show that a higher concentration (nmol ml" 1 ) of sucrose was present in lumbar CSF samples than in thoracic samples. Sucrose appears to disappear rapidly from the CSF with a half-life of approximately 30 min ( fig. 1 ).
Disposition of [ 3 H]-meptazinol following intrathecal admininstration
The results are presented in table III. Thoracic CSF samples could only be collected from one of the monkeys up to the 90-min sample, although lumbar samples were readily collected thereafter. This was probably caused by dislodgement of the needle in the thoracic region. An attempt to retap The decay of meptazinol in the CSF is shown in figure 2 . The rate of decay from both the lumbar and thoracic regions appear to be the same with a half-life of approximately 35 min. The mean lumbar concentrations are higher than the thoracic concentration and once again, indicate a probable cranio-caudal flow of the CSF.
At the end of the study, concentrations of tritiated meptazinol in the brain and spinal cord of one monkey (465) were assayed. The results of the assay, at various levels of the brain and spinal cord, are presented in table IV. It appears that the majority of the injected material was distributed within the spinal tissue at or near the site of injection. 
Disposition of meptazinol following i.m. administration
The concentrations of meptazinol (measured as total tritium) in the CSF and in the plasma following i.m. administration are presented in table V. In animals 464 and 465, samples could not be collected at 150 min and only a very small amount (< 0.2 ml) could be collected at 180 min, at which time the study was terminated.
The results indicate that appreciable concentrations of meptazinol were achieved in the CSF within 30 min of i.m. administration. Peak radioactivity in CSF and plasma was achieved at 60 min and 45-67 % of peak plasma radioactivity was present in CSF up to 180 min from the time of administration. Since the radioactivity in CSF reflects mainly unchanged meptazinol and the radioactivity in plasma reflects both unchanged meptazinol and its glucuronide conjugate, it can be assumed that appreciable amounts of meptazinol would persist in the CSF for up to 180 min from the time of administration. Figure 3 illustrates the radioactivity present in the CSF and plasma after i.m. administration.
DISCUSSION
Although the intrathecal administration of opioid analgesics has gained widespread use as an effective means of producing pain relief, there are still many fundamental questions to be addressed. For instance, little is known about the spread of solutions injected to the spinal canal or the diffusion/transport of compounds from the CSF into tissues of the spinal cord. The rate of disappearance of intrathecally injected analgesics and their relative binding to spinal tissue has been shown to depend upon the lipophilicity of the compound (Bullingham, McQuay and Moore, 1982; Camporesi and Redick, 1983; Cousins and Mather, 1984) . Thus highly charged lipophilic compounds such as fentanyl and pethidine (heptane:water partition coefficients of 19.35 and 3.4, respectively, at pH 7.4) have been shown to disappear rapidly from CSF and bind to spinal tissue. In contrast, morphine, which is hydrophilic (heptane:water coefficient of < 0.00001 at pH 7.4), tends to persist for a much longer period in the CSF. Meptazinol (heptane: water partition coefficient of 0.48 at pH 8) has a lipophilicity intermediate between those of morphine and pethidine, and would therefore be expected to persist in CSF for a shorter period than morphine.
The results of the present study appear to be consistent with this prediction, since the Ti of meptazinol, after intrathecal injection, was relatively short (about 35 min); yet in the one animal sacrificed, concentrations of 387-632 |imol ml" 1 were apparent in homogenates of spinal tissues 4 h after intrathecal administration. This persistence is apparently at variance with the short duration of analgesia seen following the extradural administration of meptazinol in clinical studies (Rao et al., 1985) . It seems possible that meptazinol, when taken up by spinal tissue, may not be available for interaction with opioid receptors, although the tissue concentrations are well in excess of those required to activate these receptors (Pasternak et al., 1983) .
The other pertinent factor affecting distribution of intrathecally injected analgesics is the spread of the injected agents within the CSF. The question of particular relevance is whether the spread is predominantly cranial or caudal to the site of injection, since a cephalad spread has been incriminated in causing the severe respiratory depression seen several hours after intrathecal administration of morphine in man (Davies, Cleaver-Tolhurst and James, 1980a, b) . Previous studies in monkeys (Reiselbach et al., 1962) have shown that the volume of injected material is an important factor determining the extent of distribution from the lumbar sac. When this volume was 10% or more of the total volume of CSF, then significant concentrations of the injected solution were present in the basal cisterns. In the present study, the monkeys weighed 4.8-5.9 kg and, hence, would have had CSF volumes ranging from 12 to 16 ml (Reiselbach et al., 1962) . With an injectate volume of 0.1 ml, representing only about 0.6-1 % of the total CSF volume, this factor would be insignificant. Although some workers (Davies, Cleaver-Tolhurst and James, 1980a, b; Gjessing and Tomlin, 1981) have suggested that, in man, intrathecally injected morphine forms a reservoir within the CSF and spreads cephalad to the basal cistern and the brain, extensive work in animals (Yaksh and Rudy, 1976; Yaksh, 1978; Yaksh and Reddy, 1981) has failed to show this. Camporesi and Redick (1983) meanwhile suggest that, in man, coughing or straining may cause cephalad spread of intrathecally administered analgesics. The results of the present study tend to support the work of Yaksh (1978) and to indicate a possible cranialcaudal flow of intrathecally injected agents. This suggestion is based on the finding that in one monkey, in which a non-metabolizable extracellular water marker ([ 14 C]-sucrose) was injected at T12-L1, higher concentrations were obtained at L3-4 than at the T9-10 sample site. A similar mean concentration difference was seen in monkeys injected intrathecally with [ 3 H]-meptazinol. However, with sample volumes of 0.25-0.75 ml, the apparent cranio-caudal flow may be an experimental artefact; removal of fluid from the lumbar region could have resulted in a flow of undiluted agent down the cord, whereas simultaneous removal from the thoracic region could have led to caudal diffusion and dilution with CSF from the cisterna magna. However, it remains that there was a greater concentration of meptazinol within the cord tissue near the injection site, with less than 5 % of that concentration being present in cord tissue cranial to this site and even lower concentrations achieved within the brain. It is likely, therefore, that little or no meptazinol would reach the brain by either cephalad diffusion or systemic redistribution.
The study on the disposition of meptazinol following i.m. administration showed that peak concentrations of meptazinol were attained in the CSF and plasma at about the same time. This is consistent with rapid equilibration across the blood-brain barrier. In addition, between 49 and 67 % of peak plasma concentrations were present within the CSF up to 180 min after i.m. administration.
CONCLUSION
On the basis of these primate studies, meptazinol injected intrathecally should give rapid but short acting pain relief with minimal side effects such as a CNS depression. The results of a preliminary study of extradurally administered meptazinol in the control of pain following major abdominal surgery (Rao et al., 1985) have, indeed, shown that pain relief is achieved relatively quickly, but is of short duration.
Although this study did not give a clear indication of the direction of spread of intrathecally administered agents, it did show that a variety of factors may contribute to this. It is likely that agents such as morphine that persist in CSF can move, either actively or passively, cephalad to the brain from the point of intrathecal injection along a concentration gradient, or because of mechanical movement of the subject. A similar hypothesis has been proposed for the distribution of morphine in CSF following intrathecal administration in sheep (Payne and Inturrisi, 1985) . However, with more lipophilic compounds, including meptazinol, minimal cephalad flow should occur because of a greater binding to spinal tissue with relatively low concentrations present within the CSF.
